Financing, Equity Capital Markets
Cogent Biosciences
06/23
|
$150.0 Million
Âé¶¹´«Ã½ served as bookrunner for Cogent Biosciences on a confidentially marketed follow on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma